Whitepapers

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

The Future of Therapeutics: Syngene Leading the Charge with Targeted Protein Degradation Platform
Introduction In this exclusive interview Kenneth Barr, Senior Vice President – Research Services at Syngene International, sheds light on how Syngene is uniquely positioned to...
Forging the Future: Why Strategic Outsourcing in Biologics is No Longer Optional, It's Essential for Success
Introduction Biologics Outsourcing: From Option to Imperative The biologics revolution is in full swing, and as innovation accelerates, so does the complexity of bringing these...
4x the Performance, Zero Compromise: How Functionalized Polymers Are Changing the Rules
Introduction In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity. The global specialty polymer market,...
Elevating Patient Safety: Syngene’s Leadership in Nitrosamine Testing and Comprehensive Analytical Development Services
Introduction The pharmaceutical industry has been forced to reckon with the increasing discovery of nitrosamine impurities in drugs, compounds known for their carcinogenic potential. This...
The $100 Billion Frontier: Untapped Potential in Animal Health Innovation
Introduction The global animal health market is a staggering $60 billion industry, projected to reach $100 billion by 2030. This phenomenal growth reflects a confluence...
SynWeaveâ„¢: Revolutionizing Biopharma Manufacturing by Improving Titer, Timelines and Manufacturability
Introduction Since the establishment of Chinese Hamster Ovary (CHO) cells in the 1950s, the production of therapeutic proteins has seen continuous innovation and growth. The...
Harnessing the Power of Upstream Platform Integration to Accelerate Biopharma Innovation
Introduction The biopharmaceutical industry has been a hotbed of innovation in recent years, with an increasing number of novel recombinant protein therapeutics receiving the U.S....
Powering up Antibody Drug Conjugates with PROTACS
Introduction The past 20 years have brought a new generation of cancer therapeutics designed to target tumor cells or cellular processes involved with tumor cell...
Hyaluronic Acid: A wonder molecule for the cosmetic and pharma industries
Introduction Hyaluronic acid (HA) biopolymer is a naturally occurring material that helps retain moisture in the skin, eyes and lubricates the joints. However, with age,...
Bioanalytical Outsourcing Soars as Drugs Grow More Complex
Introduction The global pharma analytical testing outsourcing market is expected to reach $14.6 billion by 2030, expanding at a CAGR of 8.4%, as per ReportLinker....

To view or email, Please share your details view

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details